title: In vivo immunomodulation following intradermal injection with DNA encoding IL-18.
abstract: IL-18, a recently identified cytokine synthesized by different cell types, including Kupffer cells, activated macrophages, and keratinocytes, induces IFN-gamma production by T cells and NK cells. The cDNA encoding IL-18 with its natural signal peptide was cloned under control of the CMV promoter and injected into the skin of mice. A single intradermal injection of this construction led to efficient in vivo expression of IL-18 in cutaneous dermal cells and induced IFN-gamma mRNA production, indicating that it was produced in a biologically active form. In addition, a massive cellular infiltrate was observed in the skin 2 days after injection. When the mice were subsequently infected with Mycobacterium bovis bacillus Calmette-Guérin (BCG), they produced lower levels of anti-BCG Abs than control animals. However, in contrast to their lowered humoral immune response, the mice produced higher amounts of Ag-specific IFN-gamma after in vitro restimulation, as compared with the controls. Therefore, injection of DNA encoding IL-18 into the skin modulates both Ag-specific humoral and T cell responses upon mycobacterial infection. It increases the Th1 type response, which may be particularly useful for the development of new immunotherapeutic or immunoprotective approaches against infections by intracellular parasites, such as mycobacteria.
authors.affiliation: Laboratoire de Microbiologie Génétique et Moléculaire Institut National de la Santé et de la Recherche Médicale U447, Lille, France.
authors.forename: L
authors.initials: L
authors.lastname: Kremer
authors.forename: L
authors.initials: L
authors.lastname: Dupré
authors.forename: I
authors.initials: I
authors.lastname: Wolowczuk
authors.forename: C
authors.initials: C
authors.lastname: Locht
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000235:genetics / Q000502:physiology*; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D000942:Antigens, Bacterial / Q000096:biosynthesis; D019556:COS Cells; D002465:Cell Movement / Q000276:immunology; D004247:DNA / Q000008:administration & dosage* / Q000276:immunology*; D005260:Female; D007111:Immunity, Cellular; D007271:Injections, Intradermal; D007371:Interferon-gamma / Q000096:biosynthesis; D020382:Interleukin-18 / Q000008:administration & dosage* / Q000096:biosynthesis / Q000235:genetics*; D051379:Mice; D008807:Mice, Inbred BALB C; D009163:Mycobacterium bovis / Q000276:immunology; D010957:Plasmids / Q000008:administration & dosage / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000096:biosynthesis / Q000276:immunology; D012867:Skin / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D014162:Transfection
chemical_list: D000276:Adjuvants, Immunologic; D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D020382:Interleukin-18; D011993:Recombinant Fusion Proteins; D007371:Interferon-gamma; D004247:DNA